Tokyo - Delayed Quote JPY

Techno Medica Co., Ltd. (6678.T)

1,800.00
+4.00
+(0.22%)
At close: 3:30:00 PM GMT+9
Loading Chart for 6678.T
  • Previous Close 1,796.00
  • Open 1,800.00
  • Bid 1,784.00 x --
  • Ask 1,800.00 x --
  • Day's Range 1,781.00 - 1,800.00
  • 52 Week Range 1,550.00 - 2,035.00
  • Volume 3,000
  • Avg. Volume 4,835
  • Market Cap (intraday) 12.474B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 11.34
  • EPS (TTM) 158.77
  • Earnings Date May 9, 2025
  • Forward Dividend & Yield 136.00 (7.57%)
  • Ex-Dividend Date Mar 28, 2025
  • 1y Target Est --

Techno Medica Co., Ltd. engages in the research and development, manufacture, sale, import, and export of in-vitro diagnostic analyzers in Japan. The company offers automated tube selecting and labeling systems, RFID specimen management, inspection reception systems, reception and collation systems, automated urine aliquot and labeling systems, pre-analytical instruments, and blood and urine collection support, as well as blood gas, electrolytes, erythrocyte sedimentation rates, and ion selective electrode-certificated serums. It also provides consumables and after sales services. Techno Medica Co., Ltd. was incorporated in 1987 and is headquartered in Yokohama, Japan.

www.technomedica.co.jp

237

Full Time Employees

March 31

Fiscal Year Ends

Recent News: 6678.T

View More

Performance Overview: 6678.T

Trailing total returns as of 4/23/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

6678.T
1.88%
Nikkei 225 (^N225)
12.60%

1-Year Return

6678.T
9.01%
Nikkei 225 (^N225)
7.15%

3-Year Return

6678.T
31.05%
Nikkei 225 (^N225)
28.64%

5-Year Return

6678.T
17.93%
Nikkei 225 (^N225)
79.46%

Compare To: 6678.T

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 6678.T

View More

Valuation Measures

Annual
As of 4/22/2025
  • Market Cap

    12.45B

  • Enterprise Value

    2.91B

  • Trailing P/E

    11.31

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.25

  • Price/Book (mrq)

    0.91

  • Enterprise Value/Revenue

    0.28

  • Enterprise Value/EBITDA

    1.68

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    10.94%

  • Return on Assets (ttm)

    5.84%

  • Return on Equity (ttm)

    8.34%

  • Revenue (ttm)

    10.31B

  • Net Income Avi to Common (ttm)

    1.13B

  • Diluted EPS (ttm)

    158.77

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    8.95B

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 6678.T

View More

Company Insights: 6678.T

Research Reports: 6678.T

View More

People Also Watch